US Stocks Move: Regenxbio Plunges 32% Pre-market
Show original
Bitget offers a variety of ways to buy or sell popular cryptocurrencies.Buy now!
A welcome pack worth 6200 USDT for new users!Sign up now!
Glonghui, January 28｜After the U.S. Food and Drug Administration (FDA) placed a clinical hold on Regenxbio's gene therapy trial, the company's stock price on a certain exchange plummeted 32% in pre-market trading.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
The European green bond market welcomes a rare "millennium bond"
华尔街见闻•2026/03/12 18:19
LME copper futures closed down $42, at $13,000 per ton.
华尔街见闻•2026/03/12 17:56
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$69,902.44
-1.21%
Ethereum
ETH
$2,052.19
-1.23%
Tether USDt
USDT
$1
+0.00%
BNB
BNB
$648.85
-0.57%
XRP
XRP
$1.37
-2.13%
USDC
USDC
$1
-0.01%
Solana
SOL
$86.04
-2.01%
TRON
TRX
$0.2890
-0.50%
Dogecoin
DOGE
$0.09400
-0.26%
Hyperliquid
HYPE
$37.24
+2.32%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now